Rapid liquid chromatography tandem mass spectrometry determination of rivaroxaban levels in human plasma for therapeutic drug monitoring

Analytical chemistry and Drug analysis, Department of Fundamental Pharmaceutical Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy, Târgu Mureș, Romania

Cristina Maria Tătar

Internal Medicine III, Dept. M3, Faculty of Medicine, University of Medicine and Pharmacy, Târgu Mureș, Romania

Lenard Farczadi

Vim Spectrum SRL, 409 Calea Sighișoarei, Corunca, Romania

Ioan Tilea

Family Medicine, Dept. M3, Faculty of Medicine, University of Medicine and Pharmcy, Târgu Mureș, Romania

DOI: https://doi.org/10.1515/rrlm-2017-0007 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624

Journal RSS Feed

Language: English

Page range: 145 - 155

Submitted on: Nov 6, 2016

Accepted on: Jan 17, 2017

Published on: Apr 28, 2017

Published by: Romanian Association of Laboratory Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Anticoagulants,

direct factor Xa inhibitors,

rivaroxaban,

LC-MS/MS,

therapeutic drug monitoring

Related subjects:

Microbiology and virology

© 2017 Andreea Varga, Răzvan Constantin Șerban, Daniela Lucia Muntean, Cristina Maria Tătar, Lenard Farczadi, Ioan Tilea, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 25 (2017): Issue 2 (April 2017)Next article